$20.90
+0.350 (+1.70%)
At Close: Jun 03, 2026
MedTech Stocks' Q4 Earnings on Feb 22: FMS, GKOS & More
03:06pm, Tuesday, 21'st Feb 2023 Zacks Investment Research
MedTech companies' Q4 results are likely to reflect strength in customer demand. Let's see how FMS, GKOS, MMSI and DVA are placed ahead of their earnings releases.
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
Fresenius: The Company Is Climbing, And I'm At 'Buy'
07:53am, Friday, 06'th Jan 2023
I've been unfailingly bullish in the long-term on Fresenius - both the medical care, but also the main company headquartered in Germany. Fresenius has had an extremely tricky set of years, due to comp
The 9 Best 4+% Yielding Dividend Aristocrats For 2023
12:50pm, Saturday, 31'st Dec 2022 Seeking Alpha
There are no more dependable dividend growth blue-chips for the 2023 recession than dividends aristocrats. Click to read about my favorite 9 dividend stocks.
The 9 Best 4+% Yielding Dividend Aristocrats For 2023
07:50am, Saturday, 31'st Dec 2022
Dividend growth blue-chips are the best performing assets in history. There are no more dependable dividend growth blue-chips for the 2023 recession than dividends aristocrats.
Why Is Nevro (NVRO) Up 14.9% Since Last Earnings Report?
04:32pm, Friday, 02'nd Dec 2022 Zacks Investment Research
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
11 Black Friday Dividend Aristocrat Deals
12:02pm, Friday, 18'th Nov 2022 Seeking Alpha
Black Friday is a time to gorge on the world's best blue-chip bargains, not just left-over turkey. Read more here.
3 Stocks With Dividends of 3% or More to Buy on the Dip
02:30pm, Monday, 14'th Nov 2022 The Motley Fool
Three underpriced healthcare stocks provide an opportunity.
3 Stocks With Dividends of 3% or More to Buy on the Dip
09:30am, Monday, 14'th Nov 2022
Three underpriced healthcare stocks provide an opportunity.
Douglas Dynamics and Fresenius Medical have been highlighted as Zacks Bull and Bear of the Day
01:35pm, Friday, 11'th Nov 2022 Zacks Investment Research
Douglas Dynamics and Fresenius Medical have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Fresenius Medical (FMS)
12:00pm, Friday, 11'th Nov 2022 Zacks Investment Research
Profit estimates are moving in the wrong direction.
Bear of the Day: Fresenius Medical (FMS)
08:17am, Friday, 11'th Nov 2022
Profit estimates are moving in the wrong direction.
Fresenius Medical's (FMS) Q3 Earnings and Revenues Top
11:21am, Wednesday, 02'nd Nov 2022
Fresenius Medical's (FMS) third-quarter revenues benefit from strong performance across all the geographic regions and segments. However, rising costs hurt margins.
Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2022 Earnings Call Transcript
02:31pm, Monday, 31'st Oct 2022
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS ) Q3 2022 Earnings Conference Call October 31, 2022 10:30 AM ET Company Participants Dominik Heger - Head of Investor Relations Carla Kriwet - Chief Exec
Fresenius Medical cuts outlook on slower recovery, rising costs
01:10pm, Sunday, 30'th Oct 2022
Kidney dialysis provider Fresenius Medical Care (FMC) on Sunday revised down its forecast for 2022, expecting net income to decline this year, dragged down by rising labour costs and a slower than exp
Sign In
Buy FMS